bioRxivMicrobiology
PTPN14 Degradation by High-Risk Human Papillomavirus E7 Limits Keratinocyte Differentiation and Contributes to HPV-Mediated Oncogenesis
J. Hatterschide, A. E. Bohidar, M. Grace, T. J. Nulton, B. Windle, I. M. Morgan, K. Munger, E. A. White
Abstract
High-risk human papillomavirus (HPV) E7 proteins enable oncogenic transformation of HPV-infected cells by inactivating host cellular proteins. High-risk but not low-risk HPV E7 target PTPN14 for proteolytic degradation, suggesting that PTPN14 degradation may be related to their oncogenic activity. HPV infects human keratinocytes but the role of PTPN14 in keratinocytes and the consequences of PTPN14 degradation are unknown. Using an HPV16 E7 variant that can inactivate RB1 but cannot degrade PTPN14 we found that high-risk HPV E7-mediated PTPN14 degradation impairs keratinocyte differentiation. Deletion of PTPN14 from primary human keratinocytes decreased keratinocyte differentiation gene expression. Related to oncogenic transformation, both HPV16 E7-mediated PTPN14 degradation and PTPN14 deletion promoted keratinocyte survival following detachment from a substrate. PTPN14 degradation contributed to high-risk HPV E6/E7-mediated immortalization of primary keratinocytes and HPV-positive but not HPV-negative cancers exhibit a gene expression signature consistent with PTPN14 inactivation. We find that PTPN14 degradation impairs keratinocyte differentiation and propose that this contributes to high-risk HPV E7-mediated oncogenic activity independent of RB1 inactivation.\n\nSignificance StatementHuman papillomaviruses uncouple proliferation from differentiation in order to enable virus replication in epithelial cells. HPV E7 proteins are well established to promote proliferation by binding to and inactivating retinoblastoma family proteins and other cell cycle inhibitors. However, mechanisms by which high-risk HPV oncoproteins inhibit differentiation have not been defined. This paper identifies the first mechanism by which high-risk HPV E7 inhibit keratinocyte differentiation. The inhibition of differentiation requires degradation of the cellular protein PTPN14 by high-risk HPV E7 and this degradation is related to the ability of high-risk HPV oncoproteins to immortalize keratinocytes and to cause cancer.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A conserved amino acid in the C-terminus of HPV E7 mediates binding to PTPN14 and repression of epithelial differentiation
J. Hatterschide, A. C. Brantly, … E. A. White·bioRxiv·May 22, 2020
- HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14
W. J. Blakely, J. Hatterschide, E. A. White·mBioPeer-reviewed·Oct 16, 2024
- Inactivation of the RB1 and PTPN14 tumor suppressors cooperatively enables the lifespan extension activity of the human papillomavirus E7 oncoprotein
Pushkal Sinduvadi Ramesh, Angelo A. Nicolaci, … Elizabeth A White·bioRxiv·Aug 17, 2026
- ZER1 contributes to the carcinogenic activity of high-risk HPV E7 proteins
J. Nouel, E. A. White·bioRxiv·Jul 18, 2022
- YAP1 Activation by Human Papillomavirus E7 Promotes Basal Cell Identity in Squamous Epithelia
J. Hatterschide, P. Castagnino, … E. A. White·bioRxiv·Nov 10, 2021
- E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1
C. Drews, S. Case, S. Vande Pol·bioRxiv·Jan 11, 2019